Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Bristol Myers Squibb Company published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 66
» View kspr.com items only
    May 22, 2013 |Story| Reuters
  1. Immune system cancer drugs tipped to be a $35 bln market

    Reuters
    * Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...

    Tags: Chemotherapy, Weather, Oncology, AstraZeneca Plc, Science and Technology

  2. May 22, 2013 |Story| Reuters
  3. Immune system cancer drugs tipped to be a $35 billion market

    Reuters
    LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. That bullish sales forecast by analysts at U.S. bank...

    Tags: Chemotherapy, Weather, Oncology, AstraZeneca Plc, Science and Technology

  4. May 22, 2013 |Story| Reuters
  5. Inmunoterapia contra el cáncer podría ser un mercado de 35.000 mln dlrs anuales

    Reuters
    Por Ben Hirschler LONDRES, 22 may (Reuters) - Una nueva ola de medicinas que emplea el poder del sistema inmunológico para luchar contra el cáncer podría convertirse en el mayor grupo de medicamentos de la historia, con ventas potenciales de 35.000...

    Tags: Citigroup Incorporated, Roche Holding AG, AstraZeneca Plc, Amgen Inc., GlaxoSmithKline PLC

  6. May 22, 2013 |Story| Reuters
  7. U.S. RESEARCH ROUNDUP: Bristol-Myers, BlackBerry, NetApp, Home Depot

    Reuters
    May 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Carnival Corp and Bristol-Myers, on Wednesday. HIGHLIGHTS * Bristol-Myers Squibb : Citigroup raises to buy from neutral *...

    Tags: Natural Resources, Terex Corporation, Rosetta Resources Incorporated, Electronic Arts Inc., Festive Events

  8. May 22, 2013 |Story| AP Broadcast
  9. Stocks open slightly higher on Wall Street as investors watch the Federal Reserve

    NEW YORK (AP) — Stocks are opening slightly higher as investors watch for the latest moves from the Federal Reserve. The Dow Jones industrial average was up 39 points at 15,424 shortly after the opening bell Wednesday, a gain of 0.2 percent. The...

    Tags: Citigroup Incorporated, Financial Markets, Ben Bernanke, Federal Reserve, Stock Activities

  10. May 19, 2013 |Story| Reuters
  11. PRESS DIGEST - Sunday British business - May 19

    Reuters
    LONDON, May 19 (Reuters) - British newspapers reported the following business stories on Sunday: The Sunday Telegraph CARR IN POLE POSITION TO BECOME CHAIRMAN OF BAE SYSTEMS Roger Carr, Chairman of Centrica and outgoing president of the...

    Tags: Corporate Officers, Economy, Business and Finance, Royal Dutch Shell Plc, Marks & Spencer Ltd., Politics

  12. May 16, 2013 |Story| Reuters
  13. STOCKS NEWS US-Total option open interest stands at 2.74 mln contracts

    Reuters
    Real-time equity news [E U] U.S. stock market report 0940 ET 16May2013 Total option open interest stands at 2.74 mln contracts -------------------------------------------------------------------------------- A total of 19.8 million contracts changed...

    Tags: Cisco Systems Inc., Barrick Gold Corporation, Bank of America Corp.

  14. May 15, 2013 |Story| Reuters
  15. Bristol-Myers shares jump ahead of melanoma trial data

    Reuters
    CHICAGO/NEW YORK (Reuters) - Shares of drugmaker Bristol-Myers Squibb Co rose to a 10-year high on Wednesday ahead of results of an early stage trial for its new melanoma treatment, with heavy betting in the options market suggesting investors see more...

    Tags: Oncology, Annual and Special Corporate Meetings, Skin Cancer

  16. May 8, 2013 |Story| Reuters
  17. U.S. spending on medicines fell for first time in 2012

    (Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years, according to a report released on Thursday.
    Reuters
    (Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years, according to a report released on Thursday. Overall U.S....

    Tags: Lipitor (drug), AstraZeneca Plc, Patents, Copyrights and Trademarks, Health Insurance Cost, Patient Protection and Affordable Care Act

  18. May 9, 2013 |Story| Reuters
  19. Spending on drugs falls for first time in 55 years

    The amount of money Americans spend on prescription drugs fell for the first time in 55 years, according to a report from the IMS Institute of Healthcare Informatic.
    Reuters
    The amount of money Americans spend on prescription drugs fell for the first time in 55 years, according to a report from the IMS Institute of Healthcare Informatic. The expiration of patents on widley used drugs such drugs such as Lipitor and Plaviix...

    Tags: Plavix (drug), Drugs and Medicines, Lipitor (drug), AstraZeneca Plc, Prescription Drugs

  20. May 8, 2013 |Story| Reuters
  21. REUTERS SUMMIT-Faster drug approvals a tonic for pharma industry

    Reuters
    (For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Ben Hirschler NEW YORK, May 8 (Reuters) - A pickup in new drug approvals, the promise of faster regulatory decisions and more targeted medicines have...

    Tags: Biogen Idec Incorporated, Lipitor (drug), Rheumatoid Arthritis, AstraZeneca Plc, Breast Cancer

  22. May 8, 2013 |Story| McClatchy-Tribune
  23. BRIEF: Amgen announces results of colorectal cancer drug trial

    Ventura County Star
    In a head-to-head trial evaluating Amgen colorectal cancer treatment drug Vectibix (panitumumab) against Erbitux (cetuximab), the estimated overall survival ratio favored Vectibix, Amgen said Tuesday. Erbitux is made and distributed by Bristol-Myers...

    Tags: Colon Cancer, Lilly Eli & Co, Amgen Inc.

 1  2 3 4 5 6Next >
Original site for Bristol Myers Squibb Company topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Bristol Myers Squibb Company Photos
Ivonne Cabrera has been promoted to senior vice preside...
(January 23, 2013)
Ivonne Cabrera, general counsel, Dover
Lucie Howell, of Avon, has been named director of Quinn...
(May 28, 2012)
Lucie Howell
California Insurance Commissioner Dave Jones announces...
(March 18, 2011)